Metabolic catastrophe as a means to cancer cell death

Journal of Cell Science

Volumn 120, Issue 3, 2007, Pages 379-383

  Jin, Shengkan ^a,b   DiPaola, R S ^a,b,c   Mathew, Robin ^d   White, Eileen ^a,b,d  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c Department of Medicine ^*  (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

AKT; Apoptosis; Autophagy; BCL 2; Beclin1; Cancer; mTOR

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALKYLATING AGENT; BEVACIZUMAB; DEOXYGLUCOSE; ENZYME INHIBITOR; GLUFOSFAMIDE; HEXOKINASE; LONIDAMINE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; SB 204990; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL METABOLISM; CELL PROLIFERATION; CLINICAL TRIAL; DRUG MECHANISM; DRUG TARGETING; ENERGY YIELD; ENZYME INHIBITION; GENE MUTATION; GENE TARGETING; GENOMIC INSTABILITY; GLYCOLYSIS; HUMAN; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; METABOLIC STRESS; MICROENVIRONMENT; MITOCHONDRION; NONHUMAN; NUTRIENT UPTAKE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOPTOSIS; AUTOPHAGY; GLUCOSE; GLYCOLYSIS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; NECROSIS; NEOPLASMS; PROTEIN KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 33847400593     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.03349     Document Type: Article

References (45)

1. Adams, J. M. (2003). Ways of dying: multiple pathways to apoptosis. Genes Dev. 17, 2481-2495.
2. Arico, S., Petiot, A., Bauvy, C., Dubbelhuis, P. F., Meijer, A. J., Codogno, P. and Ogier-Denis, E. (2001). The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 276, 35243-35246.
3. Balkwill, F., Charles, K. A. and Mantovani, A. (2005). Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211-217.
4. Brawer, M. K. (2005). Lonidamine: basic science and rationale for treatment of prostatic proliferative disorders. Rev. Urol. 7, S21-S26.
5. Carmeliet, P. (2005). Angiogenesis in life, disease and medicine. Nature 438, 932-936.
6. Chan, S. (2004). Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer. Br. J. Cancer 91, 1420-1424.
7. Dang, C. V., Lewis, B. C., Dolde, C., Dang, G. and Shim, H. (1997). Oncogenes in tumor metabolism, tumorigenesis, and apoptosis. J. Bioenerg. Biomembr. 29, 345-354.
8. Danial, N. N. and Korsmeyer, S. J. (2004). Cell death: critical control points. Cell 116, 205-219.
9. Degenhardt, K. and White, E. (2006). A mouse model system to genetically dissect the molecular mechanisms regulating tumorigenesis. Clin. Cancer Res. 12, 5298-5304.
10. Degenhardt, K., Chen, G., Lindsten, T. and White, E. (2002). BAX and BAK mediate p53-independent suppression of tumorigenesis. Cancer Cell 2, 193-203.
11. Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., Mukherjee, C., Shi, Y., Gelinas, C., Fan, Y. et al. (2006). Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51-64.
12. Downward, J. (2004). PI 3-kinase, Akt and cell survival. Semin. Cell Dev Biol. 15, 177-182.
13. Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R. Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M. et al. (2004). Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 64, 3892-3899.
14. Faivre, S., Kroemer, G. and Raymond, E. (2006). Current development of mToR inhibitors as anticancer agents. Nat. Rev. Drug Discov. 5, 671-688.
15. Ferrara, N. and Kerbel, R. S. (2005). Angiogenesis as a therapeutic target. Nature 438, 967-974.
16. Fesik, S. W. (2005). Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 5, 876-885.
17. Gatenby, R. A. and Gillies, R. J. (2004). Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 991-899.
18. Gelinas, C. and White, E. (2005). BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis. Genes Dev. 19, 1263-1268.
19. Giaccone, G., Smit, E. F., de Jonge, M., Dansin, E., Briasoulis, E., Ardizzoni, A., Douillard, J. Y., Spaeth, D., Lacombe, D., Baron, B. et al. (2004). Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial ofthe EORTC-New Drug Development Group. Eur. J. Cancer 40, 667-672.
20. Hanaban, D. and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
21. Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H. et al. (2006). Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885-889.
22. Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A. and Thompson, C. B. (2005). ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8, 311-321.
23. Hemmings, B. A. (1997). Akt signaling: linking membrane events to life and death decisions. Science 275, 628-630.
24. Jin, S. and White, E. (2007). Role of autophagy in cancer: management of metabolic stress. Autophagy 3, 28-31.
25. Johnstone, R. W., Ruefli, A. and Lowe, S. W. (2002). Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153-164.
26. Klionsky, D. J. (2005). The molecular machinery of autophagy: unanswered questions. J. Cell Sci. 118, 7-18.
27. Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y. et al. (2005). Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 169, 425-434.
28. Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, L, Ueno, T., Koike, M., Uchiyama, Y., Kominami, E. et al. (2006). Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880-884.
29. Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T. and Mizushima, N. (2004). The role of autophagy during the early neonatal starvation period. Nature 432, 1032-1036.
30. Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T. and Thompson, C. B. (2005). Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120, 237-248.
31. Mohanti, B. K., Rath, G. K., Anantha, N., Kannan, V., Das, B. S., Chandramouli, B. A., Banerjee, A. K., Das, S., Jena, A., Ravichandran, R. et al. (1996). Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int. J. Radiat. Oncol. Biol. Phys. 35, 103-111.
32. Nelson, D. A. and White, E. (2004). Exploiting different ways to die. Genes Dev. 18, 1223-1226.
33. Nelson, D. A., Tan, T. T., Rabson, A. B., Anderson, D., Degenhardt, K. and White, E. (2004). Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. Genes Dev. 18, 2095-2107.
34. Pelicano, H., Martin, D. S., Xu, R. H. and Huang, P. (2006). Glycolysis inhibition for anticancer treatment. Oncogene 25, 4633-4646.
35. Rowinsky, E. K. (2004). Targeting the molecular target of rapamycin (mTOR). Curr. Opin. Oncol. 16, 564-575.
36. Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732.
37. Tan, T. T., Degenhardt, K., Nelson, D. A., Beaudoin, B., Nieves-Neira, W., Bouillet, P., Villunger, A., Adams, J. M. and Whiteg E. (2005). Key roles of BIM-driven apoptosis in epithelia] tumors and rational chemotherapy. Cancer Cell 7, 227-238.
38. Thompson, C. B., Bauer, D. E., Lum, J. J., Hatzivassiliou, G., Zong, W. X., Zhao, F., Ditsworth, D., Buzzai, M. and Lindsten, T. (2005). How do cancer cells acquire the fuel needed to support cell growth? Cold Spring Harb. Symp. Quant. Biol. 70, 357-362.
39. Warburg, O. (1956). On respiratory impairment in cancer cells. Science 124, 269-270.
40. White, E. (2006). Mechanisms of apoptosis regulation by viral oncogenes in infection and tumorigenesis. Cell Death Differ 13, 1371-1377.
41. Wu, H., Yang, J. M., Jin, S., Zhang, H. and Hait, W. N. (2006). Elongation factor-2 kinase regulates autophagy in human glioblastoma cells. Cancer Res. 66, 3015-3023.
42. Zeh, H. J., 3rd and Lotze, M. T. (2005). Addicted to death: invasive cancer and the immune response to unscheduled cell death. J. Immunother. 28, 1-9.
43. Zhang, Z., Li, H., Liu, Q., Zhou, L., Zhang, M., Luo, Q., Glickson, J., Chance, B. and Zheng, G. (2004). Metabolic imaging of tumors using intrinsic and extrinsic fluorescent markers. Biosens. Bioelectron. 20, 643-650.
44. Zong, W. X. and Thompson, C. B. (2006). Necrotic death as a cell fate. Genes Dev. 20, 1-15.
45. Zong, W. X., Ditsworth, D., Bauer, D. E., Wang, Z. Q. and Thompson, C. B. (2004). Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev. 18, 1272-1282.